Skip to main content
Equibles

Bridgewater Associates, LP

Position in RPRX — Royalty Pharma plc

CIK 1350694 Westport, CT
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,317,850
+$11,057,248 QoQ
Shares Held
219,687
+344.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#138
of 646 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bridgewater Associates, LP holds $349,256,528 across 27 Biotechnology names. RPRX ranks #12 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 455,392 $48,553,895
2 HALO
Halozyme Therapeutics, Inc.
 463,146 $36,250,437
3 BBIO
BridgeBio Pharma, Inc.
 448,143 $33,377,690
4 REGN
Regeneron Pharmaceuticals, Inc.
 51,333 $32,008,178
5 ALNY
Alnylam Pharmaceuticals, Inc.
 99,584 $29,977,771
6 TGTX
Tg Therapeutics, Inc.
 429,904 $23,618,925
7 EXEL
Exelixis, Inc.
 400,859 $21,810,738
8 KRYS
Krystal Biotech, Inc.
 54,489 $20,251,926

All Filings in RPRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,317,850 219,687
2024-12-31 $1,260,602 49,416
2024-06-30 $6,302,192 238,991
2024-03-31 $11,281,300 371,462
2023-12-31 $594,047 21,148
2023-09-30 $5,242,796 193,176
2023-06-30 $3,462,492 112,638
2023-03-31 $1,204,735 33,437
2022-12-31 $1,544,955 39,093
2022-09-30 $2,485,213 61,852
2022-06-30 $223,190 5,309
2022-03-31 $1,577,373 40,487
2021-12-31 $229,057 5,748
2021-06-30 $752,043 18,347
2020-12-31 $677,426 13,535